To collect lipid-lowering response data with the use of simvastatin 40 mg tablet in patients with hypercholesterolemia.
This is an open-label, prospective study to investigate lipid-lowering efficacy and sympathetic response of normotensive hypercholesterolemia patients after receiving simvastatin 40 mg once daily for 3 months. The total duration of the study will be approximately 13 weeks, comprising of a 1-week (or 4 weeks?) screening period and a 12-week active treatment period. 20 hypercholesterolemia patients with normal blood pressure will be enrolled into treatment group.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Duration of Treatment: 12 Weeks
Total cholesterol, ldl-c, hdl-c, and triglycerides
Time frame: after 12 weeks treatment
Pulse wave velocity
Time frame: after 12 weeks
Baroreflex sensitivity
Time frame: after 12 weeks treatment
Serum nitrite, nitrate and urine c-gmp levels after 12 weeks treatment
Time frame: after 12 weeks treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.